Helical structure and self-association in a 13 residue neuropeptide YY2 receptor agonist: relationship to biological activity

被引:12
|
作者
Barnham, KJ
Catalfamo, F
Pallaghy, PK
Howlett, GJ
Norton, RS
机构
[1] Biomol Res Inst, Parkville, Vic 3052, Australia
[2] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia
关键词
neuromodulatory polypeptide (neuropeptide Y); NMR spectroscopy; structure; alpha-helix; self-association; receptor interaction;
D O I
10.1016/S0167-4838(99)00214-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The solution structure and self-association behaviour of a 13 residue peptide analogue of the C-terminal region of human neuropeptide Y (NPY) have been investigated. NMR analysis of Ac[Leu(28,31)]NPY24-36, a potent Y2 receptor agonist, shows that it is unstructured in aqueous solution at 5-20 degrees C, but forms a well-defined helix (encompassing residues 25-35) in 40% trifluoroethanol/water at 20 degrees C. Sedimentation experiments show that, in contrast to many peptides in aqueous trifluoroethanol, Ac[Leu(28,31)]Npy(24-36) associates to form a trimer or, more likely, a tetramer in 40% trifluoroethanol, even though it is monomeric in water. This is consistent with the observation of inter-molecular nuclear Overhauser enhancements in trifluoroethanol. Possible models of the associated form that are consistent with the NMR data are described. The relevance of the helical structure observed in trifluoroethanol to the structure of this peptide bound to the NPY Y2 receptor is discussed. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:127 / 137
页数:11
相关论文
共 26 条
  • [21] Novel Non-Peptide Nociceptin/Orphanin FQ Receptor Agonist, 1-[1-(1-Methylcyclooctyl)-4-piperidinyl]-2-[(3R)-3-piperidinyl]-1H-benzimidazole: Design, Synthesis, and Structure-Activity Relationship of Oral Receptor Occupancy in the Brain for Orally Potent Antianxiety Drug
    Hayashi, Shigeo
    Hirao, Akiko
    Imai, Aki
    Nakamura, Hiroshi
    Murata, Yoshinori
    Ohashi, Katsuyo
    Nakata, Eriko
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (03) : 610 - 625
  • [22] Discovery of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an agonist of the α7 nicotinic acetylcholine receptor, for the potential treatment of cognitive deficits in schizophrenia:: Synthesis and structure-activity relationship
    Wishka, Donn G.
    Walker, Daniel P.
    Yates, Karen M.
    Reitz, Steven C.
    Jia, Shaojuan
    Myers, Jason K.
    Olson, Kirk L.
    Jacobsen, E. Jon
    Wolfe, Mark L.
    Groppi, Vincent E.
    Hanchar, Alexander J.
    Thornburgh, Bruce A.
    Cortes-Burgos, Luz A.
    Wong, Erik H. F.
    Staton, Brian A.
    Raub, Thomas J.
    Higdon, Nicole R.
    Wall, Theron M.
    Hurst, Raymond S.
    Walters, Rodney R.
    Hoffmann, William E.
    Hajos, Mihaly
    Franklin, Stanley
    Carey, Galen
    Gold, Lisa H.
    Cook, Karen K.
    Sands, Steven B.
    Zhao, Sabrina X.
    Soglia, John R.
    Kalgutkar, Amit S.
    Arneric, Stephen P.
    Rogers, Bruce N.
    JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (14) : 4425 - 4436
  • [23] STRUCTURE-ACTIVITY RELATIONSHIP STUDIES OF CENTRAL-NERVOUS-SYSTEM AGENTS .13. 4-[3-(BENZOTRIAZOL-1-YL)PROPYL]-1-(2-METHOXYPHENYL)PIPERAZINE, A NEW PUTATIVE 5-HT1A RECEPTOR ANTAGONIST, AND ITS ANALOGS
    MOKROSZ, JL
    PALUCHOWSKA, MH
    CHOJNACKAWOJCIK, E
    FILIP, M
    CHARAKCHIEVAMINOL, S
    DERENWESOLEK, A
    MOKROSZ, MJ
    JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (17) : 2754 - 2760
  • [24] Further structure activity relationship (SAR) study of novel hybrid N6-(2-(4-(1H-indole)piperazine-1-yl)ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine analogs: Development of highly potent and selective D3 receptor preferring agonist molecules
    Vedachalam, Seenuvasan
    Das, Banibrata
    Antonio, Tamara
    Reith, Maarten
    Dutta, Aloke
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
  • [25] Structure-Activity Relationship Study of N6-(2-(4-(1H-Indol-5-yl) piperazin-1-yl)ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine Analogues: Development of Highly Selective D3 Dopamine Receptor Agonists along with a Highly Potent D2/D3 Agonist and Their Pharmacological Characterization
    Johnson, Mark
    Antonio, Tamara
    Reith, Maarten E. A.
    Dutta, Aloke K.
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (12) : 5826 - 5840
  • [26] Structure-Activity Relationship Study of N6-(2-(4-(1H-Indol-5-yl)piperazin-1-yl)ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine Analogues: Development of Highly Selective D3 Dopamine Receptor Agonists along with a Highly Potent D2/D3 Agonist and Their Pharmacological Characterization (vol 55, pg 5826, 2012)
    Johnson, Mark
    Antonio, Tamara
    Reith, Maarten E. A.
    Dutta, Aloke K.
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (02) : 589 - 590